Evidence map›Paper›PMID 35432333›Full record

ArticleFrontiers in immunology2022

A Novel Porcine Model of Ischemia-Reperfusion Injury After Cross-Clamping the Thoracic Aorta Revealed Substantial Cardiopulmonary, Thromboinflammatory and Biochemical Changes Without Effect of C1-Inhibitor Treatment.

Erik Waage Nielsen, Yoav Miller, Ole-Lars Brekke, Joost Grond, Anh Hoang Duong, Hilde Fure, Judith Krey Ludviksen, Kristin Pettersen, Leon Reubsaet, Rigmor Solberg and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Erik Waage NielsenDepartment of Anesthesia and Intensive Care Medicine, Nordland Hospital, Bodø, Norway.
Yoav MillerInstitute of Clinical Medicine, UiT The Arctic University of Norway, Tromsø, Norway.
Ole-Lars BrekkeResearch Laboratory, Nordland Hospital Trust, Bodø, Norway.
Joost GrondResearch Laboratory, Nordland Hospital Trust, Bodø, Norway.
Anh Hoang DuongDepartment of Pharmacy, University of Oslo, Oslo, Norway.
Hilde FureResearch Laboratory, Nordland Hospital Trust, Bodø, Norway.
Judith Krey LudviksenResearch Laboratory, Nordland Hospital Trust, Bodø, Norway.
Kristin PettersenResearch Laboratory, Nordland Hospital Trust, Bodø, Norway.
Leon ReubsaetDepartment of Pharmacy, University of Oslo, Oslo, Norway.
Rigmor SolbergDepartment of Pharmacy, University of Oslo, Oslo, Norway.
Harald Thidemann JohansenDepartment of Pharmacy, University of Oslo, Oslo, Norway.
Tom Eirik MollnesResearch Laboratory, Nordland Hospital Trust, Bodø, Norway.
Nordland Hospital Trust · NOUniversity of Oslo · NOUiT The Arctic University of Norway · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ischemic injury worsens upon return of blood and innate immunity including the complement system play a central role in ischemia-reperfusion injury (IRI) as in thoracic aortic surgery. Complement component1 inhibitor (C1-INH) has been shown to reduce IRI and is a broad-acting plasma cascade inhibitor. We established a new porcine model of IRI by cross-clamping the thoracic aorta and evaluated the global changes occurring in organ function, systemic inflammatory response and organ damage with or without treatment with C1-INH-concentrate. Twenty-four piglets (8.8-11.1 kg) underwent 45 minutes clamping of the thoracic aorta at the Th8 level. Upfront 12 piglets received human saline and 12 received C1-INH (250 IU/kg) intravenously. Three sham animals received thoracic opening without clamping. Reperfusion lasted 5 hours. We studied ten cardiorespiratory markers, three hematologic markers, eleven inflammatory markers, and twelve organ damage markers over the whole experimental period. Postmortem tissue homogenates from seven organs were examined for inflammatory markers and analysed by two-way repeated-measures ANOVA, area under the curve or unpaired t-tests. By excluding sham and combining treated and untreated animals, the markers reflected a uniform, broad and severe organ dysfunction. The mean and range fold change from before cross-clamp onset to maximum change for the different groups of markers were: cardiorespiratory 1.4 (0.2-3.7), hematologic 1.9 (1.2-2.7), plasma inflammatory 19.5 (1.4-176) and plasma organ damage 2.9 (1.1-8.6). Treatment with C1-INH had only a marginal effect on the IRI-induced changes, reaching statistical significance only for the plasma complement activation product TCC (p=0.0083) and IL-4 (p=0.022) and INF-α (p=0.016) in the colon tissue. In conclusion, the present novel model of porcine global IRI is forceful with regards to central markers and could generally be applicable for pathophysiological studies. C1-INH treatment had no significant effect, but the model allows for future testing of other drugs attenuating IRI globally.

Indexed as

Aorta, ThoracicReperfusion InjuryAnimalsComplement Inactivating AgentsConstrictionHeartSwineComplement Inactivating AgentsANOVA & factor analysisC1-INH (C1 inhibitor)C1-INH concentratecomplement - immunological termsischemi/reperfusion injuryKallikrein - kinin systemporcine (pig) model

Identifiers

PMID35432333
PMCPMC9010742
OpenAlexW4220933495

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.